Zhang H, Orme JJ, Abraha F, Stish BJ, et al. Phase II evaluation of Stereotactic Ablative Radiotherapy (SABR) and immunity in (11)C-Choline-PET/CT-identified oligometastatic castration-resistant prostate cancer. Clin Cancer Res 2021 Sep 30. pii: 1078-0432.CCR-21-2510.
PMID: 34593526